Delivery Order SPE2DE24D0021-SPE2D625F4HCL
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $5,149.92 for RNA isolation and purification products on September 26, 2025, with an ultimate completion date of October 3, 2025. This fixed-price contract with economic price adjustment was issued by the Defense-related Medical Supply Chain agency and does not utilize a set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,788 on September 8, 2025, for RNA isolation and purification products. The contract, which carries a fixed price with economic price adjustment pricing structure, is a child contract with an ultimate completion date of September 18, 2025. The place of performance is Pittsburgh, Pennsylvania. This award was funded by the Defense Medical Supply Chain, a defense-oriented federal agency, and no small business set-aside...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,789.98 for RNA isolation and purification products under a fixed price contract with economic price adjustment provisions. The award was issued on August 6, 2025, with an ultimate completion date of August 13, 2025, and will be performed in Pittsburgh, PA. The contract represents an open competition award with no set-aside designation to the Medical Supply Chain, a defense-focused federal agency. This delivery...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,096.99 by the Medical Supply Chain, a defense-affiliated federal agency, on August 1, 2025, for RNA isolation and purification products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 13, 2025. Performance will be completed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,445.78 for RNA isolation and purification products by the Defense Medical Supply Chain on August 7, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is classified as a child contract under a larger vehicle. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 21, 2025. No set-aside designation was applied to this...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $4,201.61 to Fisher Scientific Company L.L.C. for RNA isolation and purification products on September 11, 2025, with an ultimate completion date of September 18, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating open competition procurement. The work will be performed in Pittsburgh, Pennsylvania, and represents a child contract under a larger...
- This federal contract award, issued by the Department of Defense's Medical Supply Chain agency, is for the delivery of RNA isolation and purification products to support federal research, testing, and healthcare initiatives. The $1,922.00 fixed-price with economic price adjustment delivery order was awarded to Fisher Scientific Company L.L.C. on August 14, 2024, with a completion date of August 21, 2024. The contract does not utilize a set-aside designation. Fisher Scientific is a major supplier...
- This is a federal contract award to Fisher Scientific Company L.L.C., a for-profit limited liability company and major supplier of scientific products, equipment, and services to government agencies. The $3,626.00 fixed-price delivery order is for RNA isolation and purification products, and was awarded on June 13, 2025 by the U.S. Department of Defense's Medical Supply Chain. The contract has a completion date of June 26, 2025 and does not utilize a set-aside designation. Fisher Scientific...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,080.20 for a nucleic acid purification system accessory by the Defense Department's Medical Supply Chain division. The contract, awarded on August 7, 2025, with an ultimate completion date of August 14, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $34,334.30 on August 22, 2025, by the Medical Supply Chain, a defense-focused federal agency. The delivery order, designated as "PRCRPLX MS CYTOKINE + CH 96 TS," procures specialized cytokine and chemistry testing supplies for performance at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of September 2, 2025. This award represents a child contract under a...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F4HCLDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,521.03 on September 26, 2025, for RNA isolation and purification products to support the Defense Department's Medical Supply Chain. The contract features fixed-price pricing with economic price adjustment provisions and will be completed by October 10, 2025, with performance at the vendor's Pittsburgh, Pennsylvania location. This award represents a child contract with no small business set-aside designation, reflecting Fisher Scientific's demonstrated competitive capability in federal procurement. The company, a major supplier of laboratory supplies and scientific equipment registered in SAM.gov since 2001, brings extensive experience delivering specialized products across multiple federal agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Agriculture. As a limited liability company operating in the life sciences supply sector, Fisher Scientific's award aligns with its established role as a critical vendor supporting medical research and healthcare initiatives across federal departments. The company's recent contract awards across open competitions and its significant Blanket Purchase Agreement with Veterans Integrated Service Network 1 for toxicology and drug testing reagents demonstrate its sustained capacity to fulfill specialized laboratory and medical supply requirements. This delivery order contributes to the Defense Department's medical supply chain operations through the provision of essential molecular biology reagents required for nucleic acid processing and analysis applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/26/25 |